Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23
Background/purpose: HIV-infected patients have a high prevalence of low bone mineral density (BMD), but BMD changes remain unclear. This cross-sectional retrospective observational study aimed to characterize the prevalence and associated factors of low BMD in HIV patients. Methods: Between 1 Januar...
Main Authors: | Kuan-Yu Chen, Ching-Hsun Wang, Te-Yu Lin, Chan-Yuan Chang, Chang-Lin Liu, Yu-Chun Hsiao, Ching-Ching Hung, Ning-Chi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118218302196 |
Similar Items
-
Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
by: Steve R. Martinez, et al.
Published: (2013-02-01) -
Fibroblast growth factor-23 and Klotho in bone/mineral and parathyroid disorders
by: Krajisnik, Tijana
Published: (2009) -
Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
by: Cheng Q, et al.
Published: (2018-11-01) -
Intact Parathyroid Hormone Suppression in Primary Hyperparathyroidism by Hypercalcemia of Malignancy
by: Nadia Barghouthi, MD, MPH, et al.
Published: (2018-07-01) -
Serum Intact-Parathyroid Hormone Level following Total Knee Arthroplasty
by: Kyriakos A Papavasiliou, et al.
Published: (2012-04-01)